AHR | Aryl hydrocarbon receptor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATF2 | Activating transcription factor 2 | Enzymes Transcription factors
| | | | | Expressed in all |
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | Transcription factors
| | | | | Expressed in all |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | Transcription factors
| | | | | Expressed in all |
CLOCK | Clock circadian regulator | Enzymes Transcription factors
| | | | | Expressed in all |
CREB1 | CAMP responsive element binding protein 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CREM | CAMP responsive element modulator | Transcription factors
| | | | | Expressed in all |
FOSL2 | FOS-like antigen 2 | Transcription factors
| | | | | Expressed in all |
HIF1A | Hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
ID2 | Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ID3 | Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | Cancer-related genes Transcription factors
| | | | | Expressed in all |
JDP2 | Jun dimerization protein 2 | Transcription factors
| | | | | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
JUNB | Jun B proto-oncogene | Plasma proteins Transcription factors
| | | | | Expressed in all |
JUND | Jun D proto-oncogene | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
NCOA3 | Nuclear receptor coactivator 3 | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
NFE2 | Nuclear factor, erythroid 2 | Transcription factors
| | | | | Tissue enriched |
NFE2L2 | Nuclear factor, erythroid 2-like 2 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
TCF3 | Transcription factor 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Transcription factors
| | | | | Tissue enhanced |
TFE3 | Transcription factor binding to IGHM enhancer 3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
USF1 | Upstream transcription factor 1 | Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |